Serial Number
98214461
Owner
ReNAgade Therapeutics Management Inc.Attorney
Jonathan M. GelchinskyFiling Date
Oct 9, 2023
PRL Trademark
Serial Number: 98214461
Trademark Classes
Class 1 - Chemicals
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Owner Contact Info
500 Forge Rd.
Watertown, MA 02472
Entity Type: 03
Legal Representation
Correspondence Address
Jonathan M. Gelchinsky Pierce Atwood LLP
254 Commercial Street
Portland, ME 04101
United States
Trademark Details
Filing Date
October 9, 2023
Registration Date
Not Registered
Published for Opposition
December 31, 2024
Goods & Services
Lipids, lipid nanoparticles, lipid formulations, nucleic acid molecules, enzymes, polypeptides, and small molecule compounds for medical use; pharmaceutical preparations and therapeutic agents, namely, for RNA, gene therapy and mRNA regulation; pharmaceutical and biological preparations for medical use for the treatment of genetic and genomic disorders by gene therapy and mRNA regulation for use in human and animal therapeutics; pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the prevention and treatment of genomic disorders in humans and animals; pharmaceutical preparations for gene therapy and mRNA regulation
Chemical and biological agents for scientific and research use, namely, lipids, lipid nanoparticles, lipid formulations, nucleic acids and modified nucleic acids, namely, short RNAs and messenger RNAs; nucleic acid sequences for scientific purposes, research purposes, and laboratory purposes other than medical and veterinary purposes
Research and development in the field of technology and engineering of lipids, lipid nanoparticles, lipid formulations and RNAs for use in gene therapy and mRNA regulation; development of new technology for others for enabling the engineering and modification of lipids, lipid nanoparticles, lipid formulations, RNAs, namely, developing molecular and cellular biology reagents, techniques, and assays for use in pharmaceutical and biomedical industry
